Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,267,000 | 1,264,000 | 1,394,000 | 1,552,000 | 1,825,000 |
| Income taxes - deferred | 66,000 | 51,000 | -176,000 | -225,000 | -475,000 |
| Accounts receivable | -216,000 | -195,000 | -57,000 | -229,000 | 170,000 |
| Accounts payable and accrued liabilities | 357,000 | 158,000 | -75,000 | 121,000 | -471,000 |
| Other Working Capital | 7,000 | -582,000 | -396,000 | -128,000 | -366,000 |
| Other Operating Activity | 116,000 | 336,000 | -1,418,000 | 335,000 | 428,000 |
| Operating Cash Flow | $1,597,000 | $1,032,000 | $-728,000 | $1,426,000 | $1,111,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -337,000 | -215,000 | -218,000 | -269,000 | -302,000 |
| Net Acquisitions | -136,000 | -1,890,000 | -45,000 | 0 | 0 |
| Purchase Of Investment | -12,000 | -27,000 | -17,000 | -19,000 | -4,000 |
| Sale Of Investment | 14,000 | 26,000 | 22,000 | 42,000 | 8,000 |
| Purchase Sale Intangibles | -3,000 | -57,000 | -50,000 | -14,000 | -7,000 |
| Other Investing Activity | 20,000 | 18,000 | 5,000 | 669,000 | 44,000 |
| Investing Cash Flow | $-454,000 | $-2,145,000 | $-303,000 | $409,000 | $-261,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 661,000 | 3,291,000 | 6,836,000 | 2,100,000 | 3,455,000 |
| Debt Repayment | -1,460,000 | -1,710,000 | -7,846,000 | -3,440,000 | -5,642,000 |
| Common Stock Issued | 0 | 0 | 675,000 | N/A | N/A |
| Other Financing Activity | -69,000 | -106,000 | -139,000 | -173,000 | -107,000 |
| Financing Cash Flow | $-868,000 | $1,475,000 | $-474,000 | $-1,513,000 | $-2,294,000 |
| Exchange Rate Effect | -36,000 | 9,000 | -23,000 | -19,000 | 16,000 |
| Beginning Cash Position | 962,000 | 591,000 | 2,119,000 | 1,816,000 | 3,244,000 |
| End Cash Position | 1,201,000 | 962,000 | 591,000 | 2,119,000 | 1,816,000 |
| Net Cash Flow | $275,000 | $362,000 | $-1,505,000 | $322,000 | $-1,444,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,597,000 | 1,032,000 | -728,000 | 1,426,000 | 1,111,000 |
| Capital Expenditure | -340,000 | -272,000 | -268,000 | -283,000 | -309,000 |
| Free Cash Flow | 1,257,000 | 760,000 | -996,000 | 1,143,000 | 802,000 |